Soc. Generale Call 13 GSK 16.09.2.../ DE000SD5TRH2 /
7/6/2022 8:45:55 AM | Chg.+0.03 | Bid11:05:21 AM | Ask11:05:21 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
5.71EUR | +0.53% | 5.78 Bid Size: 25,000 |
5.82 Ask Size: 25,000 |
Gsk PLC ORD 25P | 13.00 GBP | 9/16/2022 | Call |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2